SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

SPARC reports net loss of Rs 1.47 crore in Q2 FY15

03 Nov 2014 Evaluate

Sun Pharma Advanced Research Company (SPARC) has reported results for the second quarter ended September 30, 2014.

The company has reported a net loss of Rs 1.47 crore for the quarter as compared to a net loss of Rs 7.65 crore for the same quarter in the previous year. Total income of the company has increased by 61.32% at Rs 46.59 crore for quarter under review as compared to Rs 28.88 crore for the quarter ended September 30, 2013.

Sun Pharma Advanced Research Company is an international pharmaceutical company engaged in research and development of drugs and delivery systems.

Sun Pharma Adv. Res Share Price

235.20 -2.60 (-1.09%)
23-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 436.10
Indegene 530.00
CMS Info Systems 300.00
JITF Infralogistics 319.75
Sagility 40.02
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: